Sorrento Therapeutics, a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced that the U.S. Bankruptcy Court for the Southern District of Texas granted...
Read Story
March 30, 2023, 07:00 AM
|
Sorrento Therapeutics, Inc., an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, announces it has entered into a loan and security agreement with Hercules Capital, Inc. for...
Read Story
November 29, 2016, 07:23 AM
|